(Q52009281)

English

Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP.

scientific article published on 22 August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

follicular lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

Sampsa Hautaniemi

9

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

10

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

object named as

Sirpa Leppä

11

0 references

author name string

Antti Harjunpää

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

Minna Taskinen

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

Matti Nykter

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

Marja-Liisa Karjalainen-Lindsberg

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

Heidi Nyman

5

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

Outi Monni

6

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

Samuli Hemmer

7

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

language of work or name

0 references

publication date

22 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

135

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

33-42

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Variation in gene expression patterns in follicular lymphoma and the response to rituximab

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

From the bench to the bedside: ways to improve rituximab efficacy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Inducible expression of macrophage receptor Marco by dendritic cells following phagocytic uptake of dead cells uncovered by oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Rituximab (anti-CD20) therapy of B-cell lymphomas: direct complement killing is superior to cellular effector mechanisms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Concurrent administration of granulocyte colony-stimulating factor or granulocyte-monocyte colony-stimulating factor enhances the biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Rituximab: mechanism of action and resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

TGFbeta-mediated activation of Smad1 in B-cell non-Hodgkin's lymphoma and effect on cell proliferation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Ephrin stimulation modulates T cell chemotaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Ephrin-A1 induces c-Cbl phosphorylation and EphA receptor down-regulation in T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Follicular lymphoma international prognostic index.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Activation of the p21(CIP1/WAF1) promoter by bone morphogenetic protein-2 in mouse B lineage cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06255.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2006.06255.X

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16925574

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52009281&oldid=1561093983"